Background
The oral cavity is one of the most crucial routes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and the virus is present in high concentrations in the saliva of patients with coronavirus disease 2019 (COVID-19) [
1]. Several reports have suggested that COVID-19 patients exhibit dysbiosis of the oral microbiome [
2‐
4]. Furthermore, a decrease in the alpha diversity of the oral microbiome is correlated with the severity of COVID-19, and oral dysbiosis is associated with increased levels of inflammatory cytokines and a decreased IgA response [
5]. However, these cross-sectional studies did not explain whether dysbiosis of the oral microbiome was the cause of or resulted from COVID-19.
Vaccination is a crucial strategy in the fight against COVID-19, and its application is increasing worldwide. Though there is a possibility of alterations in the oral and intestinal microbiomes of vaccinated individuals, these microbiomes have not yet been analyzed [
6]. Alterations in the microbiome might provide some beneficial information for understanding the health conditions of vaccinated individuals. However, it is also speculated that changes in the oral microbiome might directly affect oral health conditions, in addition to possibly modifying susceptibility to COVID-19 [
2‐
4]. Therefore, potential environmental factors that might affect the oral microbiome composition should be excluded as much as possible to investigate the oral microbiome. In this study, we collected saliva from participants working as dental professionals after confirming their oral health conditions and systemic health and observed alterations in their oral microbiome following COVID-19 vaccination.
Discussion
In this study, we performed comprehensive analyses of the saliva microbiome using next-generation sequencing (NGS) before and after COVID-19 vaccination. In addition, we examined the DMFT index and CPI. We found a significant difference in the alpha diversity (observed OTUs) and beta diversity of the flora among the Before, After1, and After2 groups. Consistent with our study, several other studies have demonstrated the alterations in the diversity of the oral and gut microbiomes through comprehensive analyses using NGS [
11,
12]. For example, increased diversity of the oral microbiota has been found in patients with periodontal diseases and dental caries [
13], whereas decreased diversity has been shown in patients with smoking habits and oral cancer [
14,
15]. Decreased gut microbiota diversity has been found in pathological and non-beneficial conditions, including host aging, dietary changes, and psychological stress [
12]. Obesity, high-energy feeding, and aging are most consistently associated with decreased gut microbial diversity [
16,
17]. Moreover, patients with obesity show a significant reduction in oral and gut microbiota diversity [
18]. Oral microbiota diversity is mainly affected by local factors such as the status of periodontal disease and dental caries. In this study, saliva samples were collected from dental professionals who properly managed their own oral conditions after periodontal and dental caries status was examined. The analyses revealed no significant increases in the proportion of cariogenic bacteria, such as
Streptococcus spp. and periodontal bacteria, such as
Porphyromonas spp. The clinical indices, including the DMFT index and CPI, did not significantly differ during the experimental period. These results suggest that COVID-19 vaccination does not affect the onset or progression of oral pathogenic bacteria, dental caries, or periodontal disease.
The local factors affecting the diversity of the oral microbiota were minimal in our study. Therefore, the increased diversity of the oral microbiota in our study might not be greatly affected by local factors. A previous study showed that oral microbiota diversity was markedly lower in the modern population than in the historical population, indicating that low diversity might contribute to chronic oral disease with a post-industrial lifestyle [
19]. Therefore, it can be inferred that the increased diversity of the oral microbiota following vaccination could benefit oral health.
ANCOM showed that the abundance of the genus
Bacteroides was significantly lower after vaccination than before vaccination.
Bacteroides spp. are normal microbiota of the oral cavity and the gut [
20]. Although the members of the genus
Bacteroides are not pathogenic with respect to particular oral diseases, they can cause opportunistic infections. Several studies have shown the relationship between its abundance and COVID-19 severity. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) receptor, highly expressed in various body organs, including oral and nasal mucosa, the lung, heart, and gastrointestinal tract, to enter the host [
21,
22]. In mice, ACE2 expression in the intestine is suppressed by
Bacteroides spp. [
23]. Patients with COVID-19 have an altered fecal microbiome, and the fecal
Bacteroides spp. content is inversely correlated with COVID-19 severity [
24]. These studies indicated that if oral
Bacteroides spp. also suppress ACE2 expression, the reduction in
Bacteroides spp. in the oral microbiome after COVID-19 vaccination might be a risk factor for increased ACE2 expression. In contrast, an abundance of the genus
Bacteroides is also associated with a lack of endotoxin tolerance and increased autoimmune activity [
25], suggesting that decreased abundance of the genus
Bacteroides might ameliorate the inflammatory responses. Therefore, further studies are necessary to clarify the effect of the abundance of the genus
Bacteroides in the oral microbiome on COVID-19 susceptibility.
We performed feature volatility and LME analyses to determine whether the relative abundances were impacted by the COVID-19 vaccination. Although we found four genera, including Lachnoanaerobaculum, Moryella, Parvimonas, and Peptostreptococcus, to be differentially abundant among the groups, the estimated values for these genera were small (0.000). These genera, belonging to the phylum Firmicutes, may be involved in glycometabolism in oral lesions, although the involvement may not be close.
We identified alterations in the abundance of 60 pathways, including the enrichment of several carbohydrate metabolism-related pathways, between the Before and After2 groups. A recent study showed high abundances of pathways related to carbohydrate metabolism in a metagenomic analysis of stool samples collected from COVID-19 vaccinees, including CoronaVac and BNT162b2 vaccinees [
26]. Most of these pathways were positively correlated with the abundance of
Bifidobacterium adolescentis. The enrichment of carbohydrate metabolism-related pathways may be a characteristic phenomenon in the vaccinees. The enrichments may be correlated with the abundance of several bacterial genera in the saliva of vaccinees. Further investigations are needed to clarify this speculation.
Understanding how SARS-CoV-2 vaccines affect the microbiome composition might provide important information about the changes in the oral environment following an immune response to SARS-CoV-2 infection. This information might allow us to establish new strategies for oral health management to combat COVID-19. However, this study analyzed the samples at a single time point before the vaccination, and the exact composition of the oral microbiome might vary in different time points. Therefore, further investigations including samples collected at different time points before the vaccination could provide more reliable information on temporal fluctuations not attributable to COVID-19, reveal the influences of COVID-19 vaccination on oral and gut microbiome compositions, and clarify the underlying mechanisms.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.